Power Law company profile

Aktis Oncology

Biotech & Life Sciences · Boston, United States · Founded 2020 · IPO 2026 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$818M

Market cap · Apr/2026

Revenue

$6.5M

Latest reported FY

Investors

14 investors on Aktis Oncology's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 11 investors entered at this stage

Octagon Capital Partners

Series B+ 3 investors entered at this stage

Janus Henderson Investors

RA Capital Management

RTW Investments

Global footprint

Where Aktis Oncology has talent and traffic

Web traffic by country

7.1K monthly visits
across markets

🇺🇸 United States93%

🏳️ Hungary4.2%

🇩🇪 Germany1.4%

🇵🇭 Philippines0%

Top 4 markets shown

Patent intelligence

$95k patent portfolio · 5 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$95k

0.01% of market cap · 2362.4× smaller than top peer Ganymed Pharmaceuticals ($223M)

5 active patent families

Where Aktis Oncology innovates DiseaseNuclear physicsNuclear medicineRadiochemistryProtide

Below peer median on Legal, Strategic, Market, Technology

Quality vs same-sector peers

Aktis Oncology on the five Patsnap quality dimensions

Aktis Oncology in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Aktis Oncology concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Aktis Oncology and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Aktis Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo